CHC Partnership
to Prevent HPV and Improve Cancer Outcomes
CHC and Merck partnered to expand access to breast and cervical cancer screening and to increase HPV prevention efforts in Black, Hispanic, and other underserved populations.
Through this partnership, women and girls in the Black, Hispanic, and other underserved populations benefit from a comprehensive, community-driven service approach to address complex social and economic factors, known as social determinants of health.
CHC's focus is health access, addressing underlying issues and removing barriers so everyone can thrive. Our work is driven by community need, and we direct programs, resources and support where they have the greatest impact.
Watch: Better Access, Stronger Communities
Watch interviews and insights from our vaccination equity work in Georgia filmed at our partner convening.
Cancer Care Inequities
Although incidence of many types of cancer is lower among Black and Hispanic women, outcomes are less favorable. Other concerning trends in cancer care and incidence call for action.
- Advanced-stage cervical cancer is on the rise.
- Black and Hispanic women are still more likely to die from breast cancer than White women across the US, even though Black and Hispanic women have lower breast cancer incidence rates.
- Georgia falls behind other US states in HPV vaccination coverage and up-to-date pap and HPV testing.
- Black women in the US are 40% more likely to die from breast cancer than White women.
Our collaboration with Merck aims to advance health and improve health outcomes for people at risk for breast and cervical cancers in underserved communities by creating a scalable model for prevention and support in Atlanta, Georgia.